Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
After hours 00:56:52 | |||
| 132.28 USD | -3.19% |
|
134.32 | +1.54% |
| Market Cap | 8.51B 7.39B 6.9B 6.34B 11.95B 811B 12.16B 81.39B 31.88B 404B 31.95B 31.25B 1,334B | P/E 2026 * |
31.1x | P/E 2027 * | -182x |
|---|---|---|---|---|---|
| Enterprise Value | 7.93B 6.89B 6.44B 5.91B 11.14B 756B 11.34B 75.9B 29.73B 377B 29.8B 29.14B 1,244B | EV / Sales 2026 * |
15x | EV / Sales 2027 * | 43x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -3.19% | ||
| 1 week | -2.42% | ||
| Current month | -3.19% | ||
| 1 month | +0.50% | ||
| 3 months | +34.47% | ||
| 6 months | +54.55% | ||
| Current year | +51.45% |
| 1 week | 130.63 |  | 138.95 |
| 1 month | 125.32 | | 143.29 |
| Current year | 77 | | 143.29 |
| 1 year | 50.48 | | 143.29 |
| 3 years | 13.72 | | 143.29 |
| 5 years | 6.91 | | 143.29 |
| 10 years | 4.47 | | 143.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/06/26 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 17/02/26 | Fiscal year | Director | 54,000 | 0.0864% | ||
| 06/02/26 | Fiscal year | Director | 60,000 | 0.0960% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.19% | -2.42% | +145.74% | +612.33% | 8.51B | |
| +0.32% | +0.79% | -0.18% | +14.52% | 48.22B | |
| -2.71% | -2.99% | +398.09% | +472.12% | 38.79B | |
| -0.71% | +9.45% | +27.90% | +7.89% | 38.41B | |
| -0.71% | -3.72% | +4.94% | +52.45% | 34.88B | |
| -2.41% | +1.96% | +11.68% | +38.17% | 29.19B | |
| -0.66% | -2.73% | +35.50% | +122.17% | 16B | |
| -0.19% | -3.93% | - | - | 16.05B | |
| +0.74% | -0.41% | +2.55% | +15.82% | 13.53B | |
| -3.15% | -6.14% | -4.82% | -36.90% | 12.22B | |
| Average | -1.26% | -0.84% | +69.04% | +144.29% | 25.58B | |
| Weighted average by Cap. | -1.09% | +0.07% | +78.42% | +121.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 530M 460M 430M 395M 744M 50.5B 757M 5.07B 1.99B 25.18B 1.99B 1.95B 83.07B | 185M 160M 150M 137M 259M 17.59B 264M 1.77B 692M 8.77B 693M 678M 28.94B |
| Net income | 279M 243M 227M 208M 392M 26.62B 399M 2.67B 1.05B 13.27B 1.05B 1.03B 43.79B | -50.4M -43.81M -40.9M -37.54M -70.79M -4.8B -72.03M -482M -189M -2.4B -189M -185M -7.9B |
| Net Debt | -574M -499M -466M -428M -806M -54.7B -820M -5.49B -2.15B -27.28B -2.16B -2.11B -89.98B | -565M -491M -458M -421M -793M -53.83B -807M -5.4B -2.12B -26.84B -2.12B -2.07B -88.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | US$132.28 | -3.19% | 451,166 |
| 31/07/26 | US$136.64 | -1.44% | 548,764 |
| 30/07/26 | US$138.64 | +4.24% | 556,392 |
| 29/07/26 | US$133.00 | -2.81% | 560,653 |
| 28/07/26 | US$136.84 | +0.94% | 282,383 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
